WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Theranostics
Main Authors: Gonçalves, Céline S., Vieira de Castro, Joana, Pojo, Marta, Martins, Eduarda P., Queirós, Sandro, Chautard, Emmanuel, Taipa, Ricardo, Pires, Manuel Melo, Pinto, Afonso A., Pardal, Fernando, Custódia, Carlos, Faria, Cláudia C., Clara, Carlos, Reis, Rui M., Sousa, Nuno, Costa, Bruno M.
Format: Artigo
Jezik:Inglês
Izdano: Ivyspring International Publisher 2018
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6160775/
https://ncbi.nlm.nih.gov/pubmed/30279739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.25025
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki